Article
Production of a monoclonal antibody in plants with a humanized <i>N</i>‐glycosylation pattern
1 Jul 2007
Abstract excerpt
In recent years, plants have become an attractive alternative for the production of recombinant proteins. However, their inability to perform authentic mammalian N-glycosylation may cause limitations for the production of therapeutics. A major concern is the presence of beta1,2-xylose and core alpha1,3-fucose residues on complex N-linked glycans, as these N-glycan epitopes are immunogenic in mammals. In our...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
